Role of renin-angiotensin system and oxidative status on the maternal cardiovascular regulation in spontaneously hypertensive rats

American Journal of Hypertension

Volumn 25, Issue 4, 2012, Pages 498-504

  Ognibene, Dayane T ^a   Carvalho, Lenize C R M ^b   Costa, Cristiane A ^b   Rocha, Ana Paula M ^b   De Moura, Roberto S ^b   Castro Resende, Ângela ^b  

^a Centro Universitario Estadual da Zona Oeste   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

blood pressure; hypertension; oxidative damage; pregnancy; renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; CATALASE; DIPEPTIDYL CARBOXYPEPTIDASE; GLUTATHIONE PEROXIDASE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MESENTERY BLOOD FLOW; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; FEMALE; HYPERTENSION; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RATS; RATS, INBRED SHR; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84858709331     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.253     Document Type: Article

References (41)

1. Hytten F. Blood volume changes in normal pregnancy. Clin Haematol 1985; 14:601-612. (Pubitemid 16242421)
2. Salas SP, Rosso P, Espinoza R, Robert JA, Valdés G, Donoso E. Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol 1993; 81:1029-1033. (Pubitemid 23168755)
3. Flo K, Wilsgaard T, Vårtun A, Acharya G. A longitudinal study of the relationship between maternal cardiac output measured by impedance cardiography and uterine artery blood flow in the second half of pregnancy. BJOG 2010; 117:837-844.
4. Irani RA, Xia Y. Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol 2011; 31:47-58.
5. Brosnihan KB, Neves LA, Anton L, Joyner J, Valdes G, Merrill DC. Enhanced expression of Ang-(1-7) during pregnancy. Braz J Med Biol Res 2004; 37:1255-1262. (Pubitemid 39177420)
6. Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 2003; 12:70-88. (Pubitemid 36700689)
7. Soares de Moura R, Resende AC, Emiliano AF, Tano T, Mendes-Ribeiro AC, Correia ML, de Carvalho LC. The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat. Br J Pharmacol 2004; 141:860-866. (Pubitemid 38446187)
8. Ognibene DT, Oliveira PR, Marins de Carvalho LC, Costa CA, Espinoza LA, Criddle DN, Tano T, Soares de Moura R, Resende AC. Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors. Clin Exp Pharmacol Physiol 2009; 36:12-19.
9. Santos RA, Ferreira AJ, Simões E Silva AC. Recent advances in the angiotensinconverting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008; 93:519-527. (Pubitemid 351595060)
10. Santos RA, Ferreira AJ, Pinheiro SV, Sampaio WO, Touyz R, Campagnole-Santos MJ. Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin Investig Drugs 2005; 14:1019-1031. (Pubitemid 41131653)
11. Neves LA, Williams AF, Averill DB, Ferrario CM, Walkup MP, Brosnihan KB. Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7). Endocrinology 2003; 144:3338-3343. (Pubitemid 36904408)
12. Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB, Joyner-Grantham J. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol 2009; 7:79.
13. Brosnihan KB, Neves LA, Chappell MC. Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension? Hypertension 2005; 46:1097-1099. (Pubitemid 41533009)
14. Joyner J, Neves LA, Granger JP, Alexander BT, Merrill DC, Chappell MC, Ferrario CM, Davis WP, Brosnihan KB. Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol 2007; 293:R169-R177. (Pubitemid 47092174)
15. Racasan S, Braam B, Koomans HA, Joles JA. Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon. Am J Physiol Renal Physiol 2005; 288: F626-F636. (Pubitemid 40381728)
16. Iacono A, Bianco G, Mattace Raso G, Esposito E, d'Emmanuele di Villa Bianca R, Sorrentino R, Cuzzocrea S, Calignano A, Autore G, Meli R. Maternal adaptation in pregnant hypertensive rats: improvement of vascular and inflammatory variables and oxidative damage in the kidney. Am J Hypertens 2009; 22:777-783.
17. Ognibene DT, Moss MB, Matsuura C, Brunini TM, de Moura RS, Mendes-Ribeiro AC, Resende AC. Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy. Hypertens Res 2010; 33:899-904.
18. McGregor DD. The effect of sympathetic nerve stimulation of vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J Physiol (Lond) 1965; 177:21-30.
19. Costa CA, Amaral TA, Carvalho LC, Ognibene DT, da Silva AF, Moss MB, Valença SS, de Moura RS, Resende AC. Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension. Am J Hypertens 2009; 22:1242-1249.
20. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol 1990; 186:421-431. (Pubitemid 20279983)
21. Bannister JV, Calabrese L. Assays for superoxide dismutase. Methods Biochem Anal 1987; 32:279-312.
22. Aebi H. Catalase in vitro. Meth Enzymol 1984; 105:121-126.
23. Flohé L, Günzler WA. Assays of glutathione peroxidase. Meth Enzymol 1984; 105:114-121. (Pubitemid 14165378)
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
25. Ballejo G, Barbosa TA, Coelho EB, Antoniali C, Salgado MC. Pregnancy-associated increase in rat systemic arteries endothelial nitric oxide production diminishes vasoconstrictor but does not enhance vasodilator responses. Life Sci 2002; 70:3131-3142. (Pubitemid 34463090)
26. Knock GA, Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1996; 175:1668-1674. (Pubitemid 27021045)
27. Ashworth JR, Baker PN, Warren AY, Johnson IR. Mechanisms of endothelium-dependent relaxation in myometrial resistance vessels and their alteration in preeclampsia. Hypertens Pregnancy 1999; 18:57-71. (Pubitemid 29149858)
28. Biondi C, Pavan B, Lunghi L, Fiorini S, Vesce F. The role and modulation of the oxidative balance in pregnancy. Curr Pharm Des 2005; 11:2075-2089. (Pubitemid 40766843)
29. Reyes MR, Sifuentes-Alvarez A, Lazalde B. Estrogens are potentially the only steroids with an antioxidant role in pregnancy: in vitro evidence. Acta Obstet Gynecol Scand 2006; 85:1090-1093. (Pubitemid 44277051)
30. Arima S, Endo Y, Yaoita H, Omata K, Ogawa S, Tsunoda K, Abe M, Takeuchi K, Abe K, Ito S. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1997; 100:2816-2823. (Pubitemid 28007551)
31. Katada J, Majima M. AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol 2002; 136:484-491. (Pubitemid 34717692)
32. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996; 27:523-528. (Pubitemid 26086221)
33. Gorelik G, Carbini LA, Scicli AG. Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery. J Pharmacol Exp Ther 1998; 286:403-410. (Pubitemid 28318016)
34. Rajendran S, Chirkov YY, Campbell DJ, Horowitz JD. Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside. J Cardiovasc Pharmacol 2005; 46:459-463. (Pubitemid 41407573)
35. Resende AC, Pimentel AM, de Moura RS. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats. Clin Exp Pharmacol Physiol 2004; 31:756-761.
36. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52:415-472.
37. Bonnet F, Cooper ME, Carey RM, Casley D, Cao Z. Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion. J Hypertens 2001; 19:1075-1081. (Pubitemid 32493641)
38. Hiyoshi H, Yayama K, Takano M, Okamoto H. Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension. Hypertension 2005; 45:967-973. (Pubitemid 40628945)
39. Gironacci MM, Coba MP, Peña C. Angiotensin-(1-7) binds at the type 1 angiotensin II receptors in rat renal cortex. Regul Pept 1999; 84:51-54. (Pubitemid 29434105)
40. Fraga-Silva RA, Sorg BS, Wankhede M, Dedeugd C, Jun JY, Baker MB, Li Y, Castellano RK, Katovich MJ, Raizada MK, Ferreira AJ. ACE2 activation promotes antithrombotic activity. Mol Med 2010; 16:210-215.
41. Alenina N, Baranova T, Smirnow E, Bader M, Lippoldt A, Patkin E, Walther T. Cell type-specific expression of the Mas proto-oncogene in testis. J Histochem Cytochem 2002; 50:691-696.